Literature DB >> 10556878

Active concentration measurements of recombinant biomolecules using biosensor technology.

G Zeder-Lutz1, A Benito, M H Van Regenmortel.   

Abstract

Whereas the concentration of a biomolecule simply refers to the amount of chemical substance per unit of volume, its active concentration refers to a relational parameter that has meaning only with respect to the molecule's ability to interact specifically with one particular ligand. When proteins are studied in a biological context, it is the biologically active concentration that is relevant, and not the total concentration of correctly and incorrectly folded molecules. Using a biosensor instrument the concentration of active biomolecules in a preparation can be measured by injecting the preparation at different flow rates onto a sensor chip surface presenting a high concentration of a specific ligand. The method can be used under conditions of partial mass transport limitation and does not require a pre-established standard curve. When the method was used to measure the active concentration of several recombinant proteins it was found that the active concentration was much lower than the nominal concentration determined by conventional methods. The active concentration also depended on the ligand used in the binding assay, reflecting the fact that active concentration can only be defined with respect to one specific probe. Such discrepancies in concentration values, if undetected, may lead to erroneous conclusions regarding the properties and behaviour of recombinant proteins tested in different assays. Copyright 1999 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  1999        PMID: 10556878     DOI: 10.1002/(SICI)1099-1352(199909/10)12:5<300::AID-JMR467>3.0.CO;2-N

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  6 in total

Review 1.  Biosensor binding data and its applicability to the determination of active concentration.

Authors:  Robert Karlsson
Journal:  Biophys Rev       Date:  2016-10-17

2.  Phage display of human antibodies from a patient suffering from coeliac disease and selection of isotype-specific scFv against gliadin.

Authors:  Claudio Rhyner; Michael Weichel; Philipp Hübner; Gernot Achatz; Kurt Blaser; Reto Crameri
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 3.  How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses.

Authors:  P J Klasse
Journal:  Expert Rev Vaccines       Date:  2016-01-06       Impact factor: 5.217

Review 4.  Quality assessment and optimization of purified protein samples: why and how?

Authors:  Bertrand Raynal; Pascal Lenormand; Bruno Baron; Sylviane Hoos; Patrick England
Journal:  Microb Cell Fact       Date:  2014-12-30       Impact factor: 5.328

5.  Imaging of native transcription factors and histone phosphorylation at high resolution in live cells.

Authors:  Sascha Conic; Dominique Desplancq; Alexia Ferrand; Veronique Fischer; Vincent Heyer; Bernardo Reina San Martin; Julien Pontabry; Mustapha Oulad-Abdelghani; Kishore Babu N; Graham D Wright; Nacho Molina; Etienne Weiss; László Tora
Journal:  J Cell Biol       Date:  2018-02-12       Impact factor: 10.539

Review 6.  Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory.

Authors:  Marc H V Van Regenmortel
Journal:  Int J Mol Sci       Date:  2016-09-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.